Meet the Thalocan Team!

To effectively address challenges in clinical trial endpoint management within the immuno-dermatology therapeutic area, a strong team is essential. We are proud to introduce the talented and driven individuals who make up Thalocan Research Innovations. Their expertise and dedication help our customers capture meaningful data to identify treatments that improve patients’ quality of life.

UPDATED VASI Training

We are very excited to share our UPDATED comprehensive VASI training course! Authored by Dr. Iltefat Hamzavi, this enhanced training was designed by Thalocan Research Innovations to improve efficiency in clinical trial training management and support consistent severity assessment in #vitiligostudies. Please contact licensing@thalocan.com for details.

TAVOS: How it works

Validating new clinical scales is essential for ensuring data quality and consistent rater assessments. However, the process is often costly, complex, and too critical to leave to chance. Sponsors and research organizations need a reliable Consensus process. Scale development projects are too often abandoned due to timeline and budget constraints. To solve this, Thalocan has…

Details

Welcome, Teresa DeHaemer!

We have had extraordinary luck in assembling the team we have here at Thalocan. The streak continues today as we welcome @TeresaDeHaemer to the team, I had the pleasure of working with Teresa in my previous life and was impressed by her dedication to clients and her integrity…

THANK YOU, DID!

The Diversity in Dermatology Conference is definitely worth attending. It was a truly enlightening experience with a variety of perspectives from a broad cohort of healthcare professionals. All in attendance seemed to share a sincere commitment to advancing diversity in all its forms across the field of dermatology. hashtag#DID2025